Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib in Neoadjuvant Early Stage NSCLC
NCT01480141Phase 2Withdrawn
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2012
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of afatinib in non-small cell lung cancer (NSCLC), sponsored by Medical University of South Carolina. Planned start Jan 2012; status: withdrawn.
02
Drugs
afatinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01480141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01480141.